RAPPORT INVESTMENT AND TRADING CO PVT LTD Revised's Insider Trades & SAST Disclosures
RAPPORT INVESTMENT AND TRADING CO PVT LTD Revised's most recent trade in Bacil Pharma Ltd. was a Disposal of 417,300 Equity Shares done at an average price of Rs. 21.5 . Disclosure was reported to the exchange on Sept. 11, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for RAPPORT INVESTMENT AND TRADING CO PVT LTD Revised in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bacil Pharma | RAPPORT INVESTMENT AND TRADING CO PVT LTD (Revised) | Promoter Group | Disposal | 11 Sep 2024 | 417,300 | 500,000 (8.49%) | 7.08% | 21.5 | 8,984,469 | 09 Sep 2024 09 Sep 2024 |
Insider Trading | Equity Shares | Off Market |
| Bacil Pharma | RAPPORT INVESTMENT AND TRADING CO PVT LTD (Revised) | Promoter Group | Disposal | 11 Sep 2024 | 300,000 | 200,000 (3.40%) | 5.09% | 22.0 | 6,588,000 | 10 Sep 2024 10 Sep 2024 |
Insider Trading | Equity Shares | Off Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.